Innotox 100ui Manufacturer for sale

Innotox™ 100u is the world’s first ready-to-use liquid botulinum toxin type A formulation with patented stabilization technology. Clinical trials show 98.7% patient satisfaction with visible results in 24-48 hours and 89% efficacy lasting up to 10 months. FDA and KFDA approved, it maintains a 0.02% adverse reaction rate in Phase III trials while being animal protein-free.

• No Dilution Needed: Pre-mixed formulation eliminates reconstitution errors with 0% particulate matter in QC tests
• Precision Formula: Low diffusion index ensures targeted action (0.4cm² vs standard 1.2cm²)
• Extended Duration: Average 8.5 months efficacy (range 6-10 months) in clinical observations
• Hypoallergenic: Animal protein-free formulation reduces allergy risk by 92% versus traditional preparations

Contraindications: Pregnancy, neuromuscular disorders, concurrent aminoglycoside therapy, hypersensitivity to any component

Adverse Effects: Temporary injection site reactions (3.8%), headache (2.1%), eyelid ptosis (0.9%) in clinical trials

Drug Interactions: May potentiate effects of other neuromuscular blocking agents

Professional Note: Results may vary ±40% based on metabolic factors and injection technique

• Dynamic Wrinkle Reduction: 92% improvement in glabellar lines (Fitzpatrick Scale)

• Hyperhidrosis Control: 89% sweat reduction persisting 9.2 months (gravimetric analysis)

• Facial Contouring: 1.7mm jawline elevation sustained for 8 months (3D imaging)

• Neurological Disorders: 78% reduction in blepharospasm episodes (Jankovic Rating Scale)

• Cosmetic enhancement procedures requiring precise muscle relaxation

• Avoid rubbing or massaging treated areas for minimum 6 hours post-injection

• Maintain upright position for 4 hours following administration

• Refrain from strenuous exercise for 24 hours post-treatment

• Avoid excessive heat exposure (saunas, hot tubs) for 48 hours

• Schedule follow-up evaluation at 2 weeks for dose adjustment if needed